Management of gastrointestinal mucositis due to cancer therapies in pediatric patients: results of a case series with SAMITAL
Gastrointestinal mucositis is a common debilitating complication of chemotherapy and one for which there is currently no effective long-term treatment. To report our experience with the use of SAMITAL , a new oral suspension formulation based on the combination of three standardized extracts from ,...
Saved in:
Published in | Future oncology (London, England) Vol. 8; no. 11; pp. 1481 - 1486 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Future Medicine Ltd
01.11.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Gastrointestinal mucositis is a common debilitating complication of chemotherapy and one for which there is currently no effective long-term treatment.
To report our experience with the use of SAMITAL
, a new oral suspension formulation based on the combination of three standardized extracts from
,
fruits and Echinacea angustifolia roots in the prevention and treatment of chemotherapy-induced gastrointestinal mucositis in pediatric patients.
20 pediatric patients undergoing chemotherapy for a range of oncological conditions were followed. Patients initially received oral SAMITAL
to treat gastrointestinal mucositis and were then given SAMITAL
prophylactically to prevent recurrences with successive cycles of chemotherapy.
SAMITAL
significantly decreased gastrointestinal mucositis grade after the first episode with a reduction of mean scores from 3.2 ± 0.7 at baseline to 0.4 ± 0.6 at the end of treatment (p < 0.001). SAMITAL
reduced pain, mucosal erosions, bleeding and dysphagia/feeding impairment. SAMITAL
improved patients overall condition and quality of life after the first administration and lowered the need for parenteral nutrition. Importantly, it allowed chemotherapy cycles to be continued without complications.
Results from this case series suggest that SAMITAL
may play an important role in the prevention and treatment of chemotherapy-induced gastrointestinal mucositis in children and adolescents and as such warrants investigation in controlled studies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1479-6694 1744-8301 |
DOI: | 10.2217/fon.12.132 |